Section snippets

Funding Support and Author Disclosures

Dr Kim has received research funding from the National Institutes of Health (T32HL160522). Dr Yeh has received research funding from Boston Scientific, Abbott, and Medtronic; and has served as a consultant for Boston Scientific, Abbott, Medtronic, Edwards Lifesciences, CathWorks, and Shockwave. Dr Secemsky has received research funding from the National Institutes of Health National Heart, Lung, and Blood Institute (K23HL150290), the U.S. Food and Drug Administration, SCAI, Abbott/CSI, Becton

中文翻译：

---

什么是 Rush？：优化非 ST 段抬高型急性冠脉综合征中 P2Y12 抑制的时间

 部分片段

资金支持和作者披露

Kim 博士获得了美国国立卫生研究院 （T32HL160522） 的研究资助。Yeh 博士获得了 Boston Scientific、Abbott 和 Medtronic 的研究资助;并曾担任波士顿科学公司、雅培、美敦力、Edwards Lifesciences、CathWorks 和 Shockwave 的顾问。Secemsky 博士获得了美国国立卫生研究院国家心肺血液研究所 （K23HL150290）、美国食品和药物管理局、SCAI、雅培/CSI、Becton 的研究资助